Significant Ownership of Ph.D. Lawrence M. Blatt

Signature - Title
/s/ Lawrence M. Blatt - Lawrence M. Blatt, Ph.D.
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Ph.D. Lawrence M. Blatt.

Notify me when Ph.D. Lawrence M. Blatt files a new Schedule 13D/G report.

⭐ Subscribe ⭐

Significant Ownership of Ph.D. Lawrence M. Blatt

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALGS Aligos Therapeutics, Inc. Common Stock, par value $0.0001 per share 3.2% $930,198 175,509 Lawrence M. Blatt, Ph.D. 10 Mar 2025

Schedules 13D/G Reported by Ph.D. Lawrence M. Blatt:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.